PestleMedicine Explained

Insulin degludec

Tresiba is a long-acting basal insulin used to treat diabetes mellitus in adults, adolescents and children aged 1 year and above. It helps your body reduce your blood sugar level.

Active ingredient: Insulin degludec

Official leaflet

Key facts

  1. Use it once each day, preferably at the same time every day. If you need to change the time, leave at least 8 hours between doses.
  2. Always check the pen label before each injection to make sure it says Tresiba 200 units/mL, as mix-ups with other strengths or insulins can happen.
  3. Low blood sugar (hypoglycaemia) is very common with insulin and can be very serious, so know the warning signs and what to do.
  4. Do not stop using your insulin without talking to your doctor, as this could lead to very high blood sugar and ketoacidosis.
  5. Inject under the skin only, never into a vein or muscle, and change the injection site each time.

Who should not take insulin degludec

The leaflet says not to take it if any of these apply to you.

  • If you are allergic to insulin degludec or any of the other ingredients of this medicine

Check with a doctor or pharmacist first

Tell them before you take it if any of these apply to you.

  • Low blood sugar (hypoglycaemia): follow the guidance in section 4
  • High blood sugar (hyperglycaemia): follow the guidance in section 4
  • Switching from another type, brand or manufacturer of insulin, as your dose may need to change
  • Using pioglitazone together with insulin (risk of heart failure)
  • Eye disorder: fast improvements in blood sugar control may temporarily worsen diabetic eye disorder
  • Always check the insulin label before each injection to avoid mix-ups between strengths of Tresiba and other insulin products
Show 3 moreShow fewer
  • Poor eyesight: do not use the pen without help if you cannot read the dose counter
  • Skin changes at the injection site (thickening, shrinking or lumps): rotate injection sites and tell your doctor
  • No experience of use in children below 1 year of age

How to take insulin degludec

  • Use exactly as your doctor has told you. Your doctor will decide how much you need each day and when to check your blood sugar.
  • Inject once a day under the skin (thigh, upper arm or front of waist), preferably at the same time each day, with at least 8 hours between doses. Never inject into a vein or muscle.
  • Change the injection place within the area each day and use a new needle for every injection.
  • Do not use in insulin infusion pumps, do not use a syringe to draw insulin out of the pen, and do not use it if the insulin is not clear and colourless or the pen is damaged.
  • If you miss a dose, inject it when you notice, keeping at least 8 hours between doses. Do not inject a double dose.

Side effects

Get medical help straight away

The leaflet says to get help urgently, or to stop the medicine and speak to a doctor, if you notice any of these. In an emergency call 999.

  • Low blood sugar (hypoglycaemia) that is severe: you may become unconscious, it may cause brain damage and may be life-threatening (very common)
  • Serious allergic reaction: stop using the medicine and see a doctor straight away (rare). Signs are local reactions spreading to other parts of your body, suddenly feeling unwell with sweating, being sick (vomiting), difficulty in breathing, rapid heartbeat or feeling dizzy
  • Serious local reactions at the injection site: stop using Tresiba and see a doctor straight away (common)
  • Signs of too high blood sugar or ketoacidosis (flushed dry skin, sleepiness, dry mouth, fruity breath, passing urine more often, thirst, loss of appetite, feeling or being sick): get medical help straight away

How common each side effect is

Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.

Very common

More than 1 in 10 people

  • Hypoglycaemia (too low blood sugar)

Common

Up to 1 in 10 people

  • Local reactions at the injection site: pain
  • Local reactions at the injection site: redness
  • Local reactions at the injection site: hives
  • Local reactions at the injection site: swelling
  • Local reactions at the injection site: itching

Uncommon

Up to 1 in 100 people

  • Swelling around your joints (ankles and other joints) when you first start using the medicine
  • Lipoatrophy (shrinking of fatty tissue at the injection site)
  • Lipohypertrophy (thickening of fatty tissue at the injection site)

Rare

Up to 1 in 1,000 people

  • Serious allergic reaction to the insulin or any of the ingredients
  • Allergic reactions: hives
  • Allergic reactions: swelling of the tongue and lips
  • Allergic reactions: diarrhoea
  • Allergic reactions: nausea
  • Allergic reactions: tiredness
  • Allergic reactions: itching

Not known

The leaflet says how often is not known

  • Lumps under the skin caused by build-up of amyloid (cutaneous amyloidosis)

Not stated

The leaflet gives no frequency

  • Too high blood sugar (hyperglycaemia)
  • Ketoacidosis (build-up of acid in the blood)

If you get a side effect, you can report it to the regulator through the Yellow Card scheme.

Pregnancy and breastfeeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning a baby, ask your doctor or pharmacist for advice before using this medicine. Your insulin dose may need to change during pregnancy and after delivery, and avoiding low blood sugar is particularly important for your baby's health.

Taking it with other medicines

The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.

  • Other medicines for diabetes (oral and injectable)
  • Sulfonamides, for infections
  • Anabolic steroids, such as testosterone
  • Beta-blockers, for high blood pressure (may make it harder to recognise warning signs of low blood sugar)
  • Acetylsalicylic acid and other salicylates, for pain and mild fever
  • Monoamine oxidase (MAO) inhibitors, for depression
  • Angiotensin converting enzyme (ACE) inhibitors, for some heart problems or high blood pressure
  • Danazol, for endometriosis
  • Oral contraceptives (birth control pills)
  • Thyroid hormones, for thyroid problems
Show 7 moreShow fewer
  • Growth hormone, for growth hormone deficiency
  • Glucocorticoids such as cortisone, for inflammation
  • Sympathomimetics such as epinephrine (adrenaline), salbutamol or terbutaline, for asthma
  • Thiazides, for high blood pressure or water retention
  • Octreotide and lanreotide, for acromegaly (may raise or lower blood sugar)
  • Pioglitazone, an oral medicine for type 2 diabetes (risk of heart failure when used with insulin)
  • Alcohol can raise or lower your blood sugar, so monitor it more often

Where this comes from

Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.

Product
Tresiba 200 Units/ml Solution For Injection In Pre Filled Pen
Product licence
PLPI457631287
Leaflet dated
Checked against the leaflet
Automated check
19 of 19 side effects matched to the wording of the leaflet

Other makers of insulin degludec publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.

Read the official leaflet Original on the MHRA site How we make these pages

The same facts for software and AI agents: JSON · Markdown.